期刊文献+

乳腺癌保乳手术30例治疗体会

Experiences of breast conserving surgery in treatment of 30 cases with breast cancer
下载PDF
导出
摘要 目的 探讨应用保乳手术治疗乳腺癌的临床效果.方法 选取本院普外科2004~2009年收治的30例乳腺癌保乳手术患者为研究对象,术后采取常规治疗,辅助放、化疗与内分泌治疗等.结果 患者均未出现复发与远处转移现象,随访3年生存率为100%.术后患者乳房美容效果综合满意率为96.7%.结论 应用保乳手术治疗早期乳腺癌临床较好,保留了患者的乳房外观,乳房外形改变较小,未见患者术后有出血、感染、皮下积液等并发症发生,值得临床推广应用. Objective To investigate the clinical curative effect of breast conserving surgery in treatment of breast cancer. Methods 30 cases of patients with breast cancer,who adopted breast conserving surgery in our general surgery department from 2004 to 2009,were selected as research objects.They were given postoperative regular treatment, as- sisted with radiotherapy, chemotherapy and endocrine treatment etc. Results No recurrence and distant metastasis phenomenon occurred,and the survival rate was 100% in 3 years of follow-up.The overall satisfaction rate of postoper- ative breast cosmetic effect was 96.7%. Conclusion Breast conserving surgery in treatment of early breast cancer has a good clinical effect,it reserved breast appearance with small change,and postoperative complications such as bleeding, infection and subcutaneous effusion occurred.So it is worthy of clinical popularization and application.
作者 谢翔宇
出处 《中国当代医药》 2013年第32期18-19,共2页 China Modern Medicine
关键词 乳腺癌 保乳手术 治疗 临床疗效 Breast cancer Breast conserving surgery Treatment Clinical curative effect
  • 相关文献

参考文献8

二级参考文献68

  • 1胡文娟,张蓓,潘玉林,谢蕴,刘维燕.磁共振灌注成像对局部进展期乳腺癌新辅助化疗疗效的评价[J].放射学实践,2011,26(1):25-29. 被引量:18
  • 2曹旭晨,赵凯,宁连胜.乳腺癌患者术中保留肋间臂神经的临床意义[J].中华肿瘤杂志,2006,28(7):549-550. 被引量:36
  • 3Chow LWC, Loo WTY. The differential effects ofcyclophosphamide, epirubicin and 5-fluorouracil on apoptotic marker(CPP-32), pro-apoptotic protein(p21 war-1) and anti-apoptotic protein(bcl-2) in breast cancer cells.Breast Cancer Res Treat, 2003, 80:239-244.
  • 4Schlos-Sbauer T, Sourbron S, Scholz A, et al. Dynamic breast MRI in the course ofneoadjuant chemotherapy: standardized evaluation of tumor size and enhancement parameters in correlation to differtent histopatholigic characteristics. Acadamic Radiology, 2010, 1(4) : 441-449.
  • 5Tozaki M, Oyama Y, Fukuma E, et al. Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. JPN J Radiol , 2010, 28(2):101-109.
  • 6Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol, 2003, 45: 169-184.
  • 7Furman-Haran E, Schechtman E, Kelcz F, et al. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer, 2005, 104: 708-718.
  • 8Woodhams R, Kakita S, Hata H, et al. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion -weighted imaging-comparison with contrast-enhanced MR imaging and pathologic findings. Radiology, 2010, 254: 357-366.
  • 9Balu MC, Chapellier C, Bleuse A, et al.Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Research and Treatment, 2002, 72(2):145-152.
  • 10Wasser K, Klein SK, Fink C, et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with hightemporal resolution. Eur Radiol, 2003, 13(1) : 80-87.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部